| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.12 | 0.02 |